TELEFLEX INC (TFX) Stock
TFX has an Alpha Score of 41 out of 100 (weak), computed on Nov 8, 2026 from 3 of 4 sub-scores. 8 members of Congress disclosed 16 trades in TFX since 2014: 10 purchases and 6 sales, most recently Lisa McClain (sale, Jul 22, 2025). 7 of the hedge funds AlphaScala tracks reported TFX in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $182.80M.
What is TFX's Alpha Score?
How it works →Alpha Score of 41 reflects weak overall profile with strong momentum, poor value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 8, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded TELEFLEX INC (TFX)?
Most recent: Lisa McClain (sale, Jul 22, 2025); records start Nov 10, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Lisa McClain R-MI · House | 2025-07-22 | sale | $1k – $15k |
| Lisa McClain R-MI · House | 2025-07-16 | purchase | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-02-25 | sale | $1k – $15k |
| Dan Goldman D-NY · House | 2023-07-12 | sale | $15k – $50k |
| Dan Goldman D-NY · House | 2023-04-10 | purchase | $15k – $50k |
| Susie Lee D-NV · House | 2022-11-30 | sale | $1k – $15k |
| Susie Lee D-NV · House | 2021-06-28 | purchase | $1k – $15k |
| Susie Lee D-NV · House | 2020-12-16 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all TFX political trades →Which hedge funds own TFX?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 1.44M | $182.80M | +111% |
| Baupost Group Seth Klarman | 1.41M | $178.60M | -12% |
| Citadel Ken Griffin | 1.14M | $144.63M | -3% |
| Renaissance Technologies Jim Simons (founder) | 76K | $9.60M | +34% |
| Blackstone | 24K | $3.06M | NEW |
| Marshall Wace | 17K | $2.17M | NEW |
| D.E. Shaw David Shaw | 13K | $1.70M | -89% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are TFX's key statistics?
Key statistics as of Oct 31, 2026
How does TFX's valuation compare with the Healthcare sector?
| Metric | TFX | Healthcare median | Companies in median |
|---|---|---|---|
| Net margin | -39.67% | 3.66% | 168 |
| Return on equity | -31.90% | 3.80% | 191 |
| Dividend yield (payers) | 0.62% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 8, 2026). P/E excludes loss-making companies.
TFX price chart
Powered by TradingViewWhat does TELEFLEX INC do?
Teleflex Incorporated is a global leader in the development, manufacturing, and distribution of single-use medical devices, with its headquarters in Wayne, Pennsylvania. The company's core mission is to improve patient health and quality of life by providing innovative medical technologies designed for procedures in critical care and surgery. Teleflex’s diverse product range serves key areas such as vascular and interventional access, anesthesia, cardiac care, surgical procedures, urology, emergency medicine, and respiratory care. Its portfolio includes well-recognized brands like Arrow, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift System, and Weck. A significant portion of Teleflex's sales comes from interventional cardiology, radiology, urology, vascular access, and anesthesia products. With operations spanning over 40 countries and a workforce exceeding 14,000 employees, Teleflex plays a vital role in the global healthcare sector by supporting hospitals and healthcare professionals with clinically significant, high-quality solutions for complex medical needs.